Drucker Wealth 3.0 LLC Invests $1.06 Million in UnitedHealth Group Incorporated (NYSE:UNH)

Drucker Wealth 3.0 LLC purchased a new position in UnitedHealth Group Incorporated (NYSE:UNHFree Report) during the second quarter, HoldingsChannel reports. The fund purchased 2,086 shares of the healthcare conglomerate’s stock, valued at approximately $1,062,000.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Macroview Investment Management LLC lifted its stake in UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after purchasing an additional 47 shares in the last quarter. True Wealth Design LLC bought a new position in UnitedHealth Group during the fourth quarter valued at approximately $31,000. Delos Wealth Advisors LLC boosted its position in shares of UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after acquiring an additional 53 shares during the last quarter. Bbjs Financial Advisors LLC bought a new stake in UnitedHealth Group in the second quarter worth $31,000. Finally, Signature Resources Capital Management LLC grew its stake in shares of UnitedHealth Group by 40.0% in the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after buying an additional 18 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 0.2 %

NYSE:UNH opened at $576.31 on Thursday. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88. The firm has a market cap of $530.43 billion, a PE ratio of 35.23, a price-to-earnings-growth ratio of 1.60 and a beta of 0.58. The company has a 50-day moving average of $578.80 and a 200 day moving average of $522.51. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $607.94.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The company had revenue of $98.86 billion during the quarter, compared to the consensus estimate of $98.73 billion. During the same quarter in the previous year, the firm posted $6.14 earnings per share. UnitedHealth Group’s revenue for the quarter was up 6.4% compared to the same quarter last year. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.46%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s payout ratio is 51.34%.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on UNH shares. Cantor Fitzgerald reiterated an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a research report on Monday, September 16th. Barclays increased their price target on UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. Jefferies Financial Group upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and boosted their price objective for the company from $481.00 to $647.00 in a research report on Wednesday, July 17th. Morgan Stanley lifted their price target on shares of UnitedHealth Group from $595.00 to $615.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 17th. Finally, Baird R W raised shares of UnitedHealth Group to a “strong-buy” rating in a research note on Thursday, May 30th. Two research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus price target of $614.17.

Read Our Latest Stock Analysis on UnitedHealth Group

Insider Transactions at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the sale, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at $16,812,029.88. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.